AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9440358 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent approach toward a 1:1 ratio within each cycle
Number of subjects: 0
Study 9440358 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient practice to perform movements smoothly
Number of subjects: 0
Study 7942719 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic therapy (injection or heater probe therapy)
Number of subjects: 326
Study 2681281 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulconazole nitrate 1% cream applied twice daily
Number of subjects: 229
Study 2681281 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 229
Study 1090014 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐tubocurarine
Number of subjects: 0
Study 1090014 — intervention group
Group type: EXPERIMENTAL
Intervention: THA (tetrahydro-aminacrine)
Number of subjects: 0
Study 1090014 — intervention group
Group type: COMPARATOR
Intervention: No additional drugs (Control Group I)
Number of subjects: 0
Study 30496547 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance Movement Therapy (DMT)
Number of subjects: 204
Study 30496547 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise
Number of subjects: 204
Study 30496547 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 204
Study 29309700 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (800 mcg)
Number of subjects: 14
Study 29309700 — intervention group
Group type: COMPARATOR
Intervention: Intravenous buprenorphine (300 mcg)
Number of subjects: 14
Study 27638847 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable risk prediction model
Number of subjects: 6083
Study 27638847 — intervention group
Group type: EXPERIMENTAL
Intervention: Final multivariable model
Number of subjects: 6083
Study 25542198 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively framed feedback
Number of subjects: 59
Study 25542198 — intervention group
Group type: COMPARATOR
Intervention: Negatively framed feedback
Number of subjects: 59
Study 23553992 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 or 2000 IU vitamin D3 daily for 6 months
Number of subjects: 0
Study 23553992 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher supplementation with vitamin D
Number of subjects: 0
Study 21292711 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in a modified version of the neonatal resuscitation protocol and single dose amoxicillin coupled with facilitated referral of infants to a health centre
Number of subjects: 127
Study 21292711 — intervention group
Group type: COMPARATOR
Intervention: Control birth attendants continued their existing standard of care (basic obstetric skills and use of clean delivery kits)
Number of subjects: 127
Study 21292711 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in a modified version of the neonatal resuscitation protocol
Number of subjects: 127
Study 21292711 — intervention group
Group type: COMPARATOR
Intervention: Control birth attendants continued their existing standard of care
Number of subjects: 127
Study 19691854 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (initial loading dose of 0.15 mg followed by an infusion of 0.5 mg over 24 hours; increased to 0.3 mg, 0.45 mg, and 0.6 mg at subsequent levels)
Number of subjects: 48
Study 19691854 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 48
Study 19691854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 16478814 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administration using a patch that delivers 300 microg daily
Number of subjects: 51
Study 16478814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 15577594 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial neural networks (ANNs) for diagnosing pulmonary embolism using V-P scan analysis
Number of subjects: 262
Study 15577594 — intervention group
Group type: COMPARATOR
Intervention: Clinical interpretation of V-P scans
Number of subjects: 262
Study 15577594 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ANN and clinical interpretation
Number of subjects: 262
Study 11041065 — intervention group
Group type: EXPERIMENTAL
Intervention: Single cytospin slide preparation
Number of subjects: 129
Study 9001831 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg BID
Number of subjects: 696
Study 9001831 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 800 mg BID
Number of subjects: 696
Study 9001831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg QID
Number of subjects: 696
Study 1603146 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple ligation
Number of subjects: 134
Study 1603146 — intervention group
Group type: COMPARATOR
Intervention: Invagination
Number of subjects: 134
Study 6384453 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) administered twice daily
Number of subjects: 77
Study 6384453 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor administered twice daily
Number of subjects: 77
Study 6384453 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TMP-SMZ and cefaclor
Number of subjects: 77
Study 29652596 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% feedback
Number of subjects: 30
Study 29652596 — intervention group
Group type: EXPERIMENTAL
Intervention: 67% feedback
Number of subjects: 30
Study 29652596 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 29652596 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced feedback (67%)
Number of subjects: 30
Study 29652596 — intervention group
Group type: EXPERIMENTAL
Intervention: Both feedback groups (100% and 67%)
Number of subjects: 30
Study 28368521 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 28
Study 28368521 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP
Number of subjects: 28
Study 28368521 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH
Number of subjects: 28
Study 28368521 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH-AVP
Number of subjects: 28
Study 28368521 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus AVP after CRH infusion
Number of subjects: 28
Study 28368521 — intervention group
Group type: COMPARATOR
Intervention: Bolus CRH
Number of subjects: 28
Study 28368521 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 28
Study 28003295 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised patient falls prevention education delivered by a trained health professional
Number of subjects: 30
Study 28003295 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised patient falls prevention education
Number of subjects: 30
Study 25403218 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐ISG
Number of subjects: 184
Study 25403218 — intervention group
Group type: COMPARATOR
Intervention: S‐ISG
Number of subjects: 184
Study 21422032 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical cardioversion (EC)
Number of subjects: 247
Study 21422032 — intervention group
Group type: COMPARATOR
Intervention: Intravenous propafenone treatment (PC)
Number of subjects: 247
Study 19735195 — intervention group
Group type: EXPERIMENTAL
Intervention: Borage oil enriched with vitamin E
Number of subjects: 24
Study 19735195 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 24
Study 17533063 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle change group
Number of subjects: 240
Study 17533063 — intervention group
Group type: COMPARATOR
Intervention: Health education group
Number of subjects: 240
Study 17533063 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT discontinuation
Number of subjects: 240
Study 15345498 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg injections, twice weekly for 12 weeks)
Number of subjects: 84
Study 15345498 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 84
Study 15345498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 11141221 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g intravenous ampicillin and sulbactam (AS) before incision
Number of subjects: 280
Study 11141221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 11885450 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% (K)
Number of subjects: 24
Study 11885450 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin 100,000 IU (N)
Number of subjects: 24
Study 11885450 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24
Study 7733785 — intervention group
Group type: EXPERIMENTAL
Intervention: sulperazone (cefoperazone + sulbactam)
Number of subjects: 25
Study 2914116 — intervention group
Group type: EXPERIMENTAL
Intervention: ioxaglate 280 mg I/ml
Number of subjects: 25
Study 2914116 — intervention group
Group type: COMPARATOR
Intervention: metrizoate 280 mg I/ml
Number of subjects: 25
Study 2914116 — intervention group
Group type: COMPARATOR
Intervention: metrizoate 370 mg I/ml
Number of subjects: 25
Study 2914116 — intervention group
Group type: EXPERIMENTAL
Intervention: ioxaglate 320 mg I/ml
Number of subjects: 25
Study 4262210 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisoprodol 350 mg, four times daily for four days
Number of subjects: 48
Study 4262210 — intervention group
Group type: COMPARATOR
Intervention: Butabarbital 15 mg, four times daily for four days
Number of subjects: 48
Study 4262210 — intervention group
Group type: COMPARATOR
Intervention: Placebo, four times daily for four days
Number of subjects: 48
Study 31156218 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation including mechanotherapy and cognitive stimulation using tablet technologies
Number of subjects: 100
Study 31156218 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 100
Study 28005440 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cholecalciferol (300,000 IU)
Number of subjects: 24
Study 28005440 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cholecalciferol (75,000 IU)
Number of subjects: 24
Study 25988518 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural invasion present
Number of subjects: 302
Study 25988518 — intervention group
Group type: COMPARATOR
Intervention: No perineural invasion
Number of subjects: 302
Study 23754314 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching with a pipelle de Cornier
Number of subjects: 158
Study 23754314 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 158
Study 21802681 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI)
Number of subjects: 60
Study 21802681 — intervention group
Group type: COMPARATOR
Intervention: Chromoendoscopy (CE)
Number of subjects: 60
Study 19622875 — intervention group
Group type: EXPERIMENTAL
Intervention: UniFil Bond (UB) with regular-grit diamond bur
Number of subjects: 2
Study 19622875 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond (SB) with regular-grit diamond bur
Number of subjects: 2
Study 19622875 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond (SB) with superfine-grit diamond bur
Number of subjects: 2
Study 16963037 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose GnRH antagonist
Number of subjects: 0
Study 16963037 — intervention group
Group type: COMPARATOR
Intervention: Long protocol for GnRH agonist
Number of subjects: 0
Study 15319595 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive radioguided surgery (MIRS)
Number of subjects: 266
Study 15319595 — intervention group
Group type: COMPARATOR
Intervention: Traditional bilateral neck exploration (BNE)
Number of subjects: 266
Study 10979147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive group education on the Mediterranean diet
Number of subjects: 266
Study 10979147 — intervention group
Group type: COMPARATOR
Intervention: Posted leaflet with Dutch nutritional guidelines
Number of subjects: 266
Study 9538647 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialyzed patients with chronic renal insufficiency
Number of subjects: 40
Study 9538647 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis with the presence of heparin
Number of subjects: 40
Study 1539790 — intervention group
Group type: EXPERIMENTAL
Intervention: Graseby electronic patient‐controlled analgesia system
Number of subjects: 30
Study 1539790 — intervention group
Group type: COMPARATOR
Intervention: Baxter disposable patient‐controlled analgesia system
Number of subjects: 30
Study 2862652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pl haloperidol
Number of subjects: 0
Study 2862652 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC haloperidol
Number of subjects: 0
Study 2862652 — intervention group
Group type: EXPERIMENTAL
Intervention: SS RBC haloperidol
Number of subjects: 0
Study 2862652 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal clinical response range for Pl haloperidol
Number of subjects: 0
Study 2862652 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal clinical response range for RBC haloperidol
Number of subjects: 0
Study 29532196 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using GaAlAs diode laser (780 nm, 2 J/spot) applied immediately after surgery and every 24 hours for 3 days.
Number of subjects: 82
Study 29532196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laser therapy).
Number of subjects: 82
Study 27254260 — intervention group
Group type: EXPERIMENTAL
Intervention: Low quadriceps group (LSI < 85%)
Number of subjects: 135
Study 27254260 — intervention group
Group type: EXPERIMENTAL
Intervention: High quadriceps group (LSI ≥ 90%)
Number of subjects: 135
Study 23558454 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial regulation therapy
Number of subjects: 99
Study 23558454 — intervention group
Group type: COMPARATOR
Intervention: Control (no mimicry therapy)
Number of subjects: 99
Study 23510321 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) scalpel (LigaSure; n=66)
Number of subjects: 132
Study 23510321 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound (US) scalpel (UltraCision; n=66)
Number of subjects: 132
Study 20502743 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal insulin
Number of subjects: 77
Study 20502743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 18701642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (150 mg daily for 3 months)
Number of subjects: 101
Study 18701642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 101
Study 16306318 — intervention group
Group type: EXPERIMENTAL
Intervention: Sponges with high content of saline placed in the olfactory cleft (OC)
Number of subjects: 33
Study 16306318 — intervention group
Group type: COMPARATOR
Intervention: Sponges with high content of saline placed on the respiratory epithelium
Number of subjects: 33
Study 12818461 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol
Number of subjects: 152
Study 12818461 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg estradiol
Number of subjects: 152
Study 12818461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 10083765 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg per day
Number of subjects: 25
Study 10083765 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil 300 mg twice per day
Number of subjects: 25
Study 7729302 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycemic hyperinsulinemic clamp (40 mU insulin.m-2.min-1)
Number of subjects: 16
Study 7729302 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (50 ml isotonic saline)
Number of subjects: 16
Study 2292327 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate cream applied once daily
Number of subjects: 69
Study 2292327 — intervention group
Group type: COMPARATOR
Intervention: 0.1% betamethasone valerate cream applied twice daily
Number of subjects: 69
Study 6156665 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous feedback of erection changes plus segments of erotic film delivered contingent on erection increases
Number of subjects: 30
Study 6156665 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent film segments without continuous feedback
Number of subjects: 30
Study 6156665 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent film segments
Number of subjects: 30
Study 6156665 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent film without continuous feedback
Number of subjects: 30
Study 6156665 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures concerning erectile functioning during a 1-month follow-up period
Number of subjects: 30
Study 31971158 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-trial group (257 households)
Number of subjects: 497
Study 31971158 — intervention group
Group type: COMPARATOR
Intervention: Cost-sharing group (240 households)
Number of subjects: 497
Study 31971158 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 497
Study 31971158 — intervention group
Group type: COMPARATOR
Intervention: Cost-sharing group
Number of subjects: 497
Study 31971158 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with high and medium economic status
Number of subjects: 497
Study 31971158 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with higher educated respondents
Number of subjects: 497
Study 30517622 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricuspid valve annuloplasty (TVP+)
Number of subjects: 106
Study 30517622 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (TVP-)
Number of subjects: 106
Study 29028775 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises
Number of subjects: 0
Study 29028775 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 25921551 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200mg/day)
Number of subjects: 49
Study 25921551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 23505172 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2,000 mg/d)
Number of subjects: 32
Study 23505172 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training plus placebo
Number of subjects: 32
Study 21057356 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (transfusion if hemoglobin <7.0 g/dL)
Number of subjects: 137
Study 21057356 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfusion if hemoglobin <9.5 g/dL)
Number of subjects: 137
Study 21057356 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 137
Study 20581790 — intervention group
Group type: EXPERIMENTAL
Intervention: TzCOAD (150-375 mg)
Number of subjects: 412
Study 20581790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study 16527562 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock Wave Lithotripsy (SWL)
Number of subjects: 42
Study 16527562 — intervention group
Group type: COMPARATOR
Intervention: Ureteroscopic Lithotripsy (URSL)
Number of subjects: 42
Study 15568582 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke Free Leitrim (SFL) programme
Number of subjects: 450
Study 15568582 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 450
Study 15568582 — intervention group
Group type: EXPERIMENTAL
Intervention: SFL group
Number of subjects: 450
Study 15568582 — intervention group
Group type: EXPERIMENTAL
Intervention: SFL males
Number of subjects: 450
Study 15568582 — intervention group
Group type: COMPARATOR
Intervention: Control males
Number of subjects: 450
Study 15568582 — intervention group
Group type: EXPERIMENTAL
Intervention: SFL females
Number of subjects: 450
Study 15568582 — intervention group
Group type: COMPARATOR
Intervention: Control females
Number of subjects: 450
Study 11168602 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable light-emitting diode device used to match flickering of auras.
Number of subjects: 11
Study 9494831 — intervention group
Group type: EXPERIMENTAL
Intervention: La Crosse encephalitis consideration in diagnosis
Number of subjects: 0
Study 9494831 — intervention group
Group type: EXPERIMENTAL
Intervention: Endemic areas
Number of subjects: 0
Study 7847205 — intervention group
Group type: EXPERIMENTAL
Intervention: MR scans in participants with clinical histories of stroke (100 subjects)
Number of subjects: 303
Study 7847205 — intervention group
Group type: COMPARATOR
Intervention: MR scans in participants without clinical histories of stroke (203 subjects)
Number of subjects: 303
Study 7847205 — intervention group
Group type: EXPERIMENTAL
Intervention: MR scans for large infarctlike lesions (> 3 mm)
Number of subjects: 303
Study 7847205 — intervention group
Group type: EXPERIMENTAL
Intervention: MR scans for small infarctlike lesions (≤ 3 mm)
Number of subjects: 303
Study 7847205 — intervention group
Group type: EXPERIMENTAL
Intervention: MR scans for sulcal and ventricular sizes and extent of white matter disease
Number of subjects: 303
Study 2789586 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromic catgut
Number of subjects: 100
Study 2789586 — intervention group
Group type: COMPARATOR
Intervention: Silk
Number of subjects: 100
Study 776152 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (pyrrolidine acetamide) at a dose of 80 mg/kg/day for 10 weeks.
Number of subjects: 20
Study 776152 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving customary treatment only.
Number of subjects: 20
Study 7218393 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin resuscitation (average of 31 gms during operation, 207 gms during early postoperative period, 402 gm during mobilization period)
Number of subjects: 94
Study 7218393 — intervention group
Group type: COMPARATOR
Intervention: Non-albumin resuscitation (control group)
Number of subjects: 94
Study 29968937 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT) with cut-off levels 20 μg Hb/g and 40 μg Hb/g for one sample
Number of subjects: 12383
Study 29968937 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT) with mean of two samples at cut-off 40 μg Hb/g and 80 μg Hb/g
Number of subjects: 12383
Study 29968937 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT) in men
Number of subjects: 12383